Literature DB >> 8579037

Atherosclerosis: risk factors and the vascular endothelium.

S P Glasser1, A P Selwyn, P Ganz.   

Abstract

The endothelium can respond to a local environment by releasing a variety of substances that regulate the level of vascular tone. One of the most important of these vasoregulatory substances is EDRF. The function of the endothelium is altered in a variety of pathologic and physiologic conditions. This review focused on the role of risk factors for atherosclerosis as it relates to EDRF. Atherosclerotic blood vessels respond abnormally on exposure to stimuli that release EDRF. It is now also apparent that this abnormal vascular response may precede the development of significant atherosclerosis and that normalization of the EDRF response with treatment is possible. Thus abnormal endothelium-dependent relaxation has been demonstrated in hypercholesterolemic patients with little or no evidence of coronary angiographic disease and in patients with hypertension before the development of atherosclerosis. The interaction between risk factors and the function of the vascular endothelium with development of atherosclerosis may become a useful focus for therapies that benefit patient outcomes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8579037     DOI: 10.1016/s0002-8703(96)90370-1

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  27 in total

1.  Effect of cholesterol lowering treatment on positive exercise tests in patients with hypercholesterolaemia and normal coronary angiograms.

Authors:  A P Mansur; C V Serrano; J C Nicolau; L A César; J A Ramires
Journal:  Heart       Date:  1999-12       Impact factor: 5.994

Review 2.  Role of the vascular endothelium in patients with angina pectoris or acute myocardial infarction with normal coronary arteries.

Authors:  J Sztajzel; F Mach; A Righetti
Journal:  Postgrad Med J       Date:  2000-01       Impact factor: 2.401

Review 3.  Endothelial dysfunction in HIV infection.

Authors:  Bruno R Cotter
Journal:  Curr HIV/AIDS Rep       Date:  2006-09       Impact factor: 5.071

4.  Type II diabetes does not prevent the recruitment of collateral vessels and the normal reduction of myocardial ischaemia on repeated balloon inflations during angioplasty.

Authors:  Z S Kyriakides; S Psychari; N Chrysomallis; M Georgiadis; E Sbarouni; D T Kremastinos
Journal:  Heart       Date:  2002-01       Impact factor: 5.994

5.  Comparative transcriptome analysis of rumen papillae in suckling and weaned Japanese Black calves using RNA sequencing.

Authors:  Koki Nishihara; Daichi Kato; Yutaka Suzuki; Dahye Kim; Misato Nakano; Yu Yajima; Satoshi Haga; Miwa Nakano; Hiroshi Ishizaki; Ryouka Kawahara-Miki; Tomohiro Kono; Kazuo Katoh; Sang-Gun Roh
Journal:  J Anim Sci       Date:  2018-06-04       Impact factor: 3.159

Review 6.  Epigenetics and social context: implications for disparity in cardiovascular disease.

Authors:  Karen L Saban; Herbert L Mathews; Holli A DeVon; Linda W Janusek
Journal:  Aging Dis       Date:  2014-10-01       Impact factor: 6.745

Review 7.  Angiotensin converting enzyme inhibitors: are they preferred first-line therapy?

Authors:  S P Glasser
Journal:  Curr Hypertens Rep       Date:  2000-08       Impact factor: 5.369

Review 8.  Psychosocial stress and cardiovascular disease: pathophysiological links.

Authors:  C Noel Bairey Merz; James Dwyer; Cheryl K Nordstrom; Kenneth G Walton; John W Salerno; Robert H Schneider
Journal:  Behav Med       Date:  2002       Impact factor: 3.104

9.  Vascular oxidative stress and nitric oxide depletion in HIV-1 transgenic rats are reversed by glutathione restoration.

Authors:  Erik R Kline; Dean J Kleinhenz; Bill Liang; Sergey Dikalov; David M Guidot; C Michael Hart; Dean P Jones; Roy L Sutliff
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-05-02       Impact factor: 4.733

Review 10.  The consequences of HIV infection and antiretroviral therapy use for cardiovascular disease risk: shifting paradigms.

Authors:  Jason V Baker; W Keith Henry; James D Neaton
Journal:  Curr Opin HIV AIDS       Date:  2009-05       Impact factor: 4.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.